Jun 18, 2026 06:11AM

May 6, 2026 04:46PM

Apr 17, 2026 06:46AM

Mar 27, 2026 07:00PM

Mar 26, 2026 06:39AM

Mar 25, 2026 04:04PM

Mar 25, 2026 03:05PM Sarepta Therapeutics (SRPT) PT Raised to $25 at Morgan Stanley

Mar 25, 2026 03:02PM

Mar 25, 2026 10:46AM

Mar 25, 2026 10:43AM

Mar 25, 2026 10:33AM

Mar 25, 2026 10:32AM

Mar 25, 2026 08:05AM

Mar 19, 2026 11:11AM BofA Securities on Sarepta Therapeutics (SRPT): sNDAs 'positive first step' but regulatory risk continues

Mar 19, 2026 10:57AM

Mar 19, 2026 08:30AM

Mar 17, 2026 07:37AM

Mar 16, 2026 08:34AM

Mar 12, 2026 05:06PM

Mar 9, 2026 03:22PM

Mar 3, 2026 03:44PM Sarepta Therapeutics (SRPT) PT Raised to $25 at Freedom Capital Markets

Mar 3, 2026 12:00PM

Mar 2, 2026 06:47AM

Feb 26, 2026 08:30AM

Feb 25, 2026 04:45PM

Feb 24, 2026 09:08AM

Feb 4, 2026 08:30AM

Jan 27, 2026 06:43AM JPMorgan on Sarepta Therapeutics (SRPT): 'Quick Thoughts On Elevidys 3-Year EMBARK Data'

Jan 26, 2026 12:54PM

Jan 26, 2026 08:01AM

Jan 26, 2026 05:30AM

Jan 26, 2026 05:18AM

Jan 23, 2026 04:05PM

Jan 14, 2026 06:55AM

Jan 14, 2026 04:39AM Mizuho Reiterates Outperform Rating on Sarepta Therapeutics (SRPT)

Jan 12, 2026 11:59AM

Jan 12, 2026 09:30AM

Jan 8, 2026 03:59AM

Jan 7, 2026 08:31AM

Dec 11, 2025 11:53AM

Dec 9, 2025 06:50AM

Nov 25, 2025 08:58AM Sarepta receives FDA approval for ELEVIDYS study with enhanced immunosuppression

Nov 25, 2025 07:31AM

Nov 24, 2025 07:31AM

Nov 24, 2025 07:30AM

Nov 20, 2025 03:59AM

Nov 14, 2025 02:59PM

Nov 14, 2025 02:02PM

Nov 5, 2025 10:07AM Mizuho upgrades Sarepta on confidence in Elevidys uptake

Nov 5, 2025 04:33AM

416,808 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All